Advenchen Laboratories Nanjing Ltd.
7 clinical trials · Sponsor
◉ Watch Advenchen Laboratories Nanjing Ltd.
| Record | Firm | Date |
|---|---|---|
| Catequentinib Hydrochloride (AL3818) Drug-Drug Interaction Study in Healthy Volunteers (NCT07438886) | Advenchen Laboratories Nanjing Ltd. | 2026-03-02 |
| A Study of AL8326 in Healthy Subjects (NCT07132957) | Advenchen Laboratories Nanjing Ltd. | 2025-02-21 |
| A Phase IIII Study of AL8326 in Small Cell Lung Cancer (NCT06247605) | Advenchen Laboratories Nanjing Ltd. | 2023-10-26 |
| A Study of Diet Influence of AL8326 in Chinese Healthy Adult Subjects (NCT05486598) | Advenchen Laboratories Nanjing Ltd. | 2022-06-21 |
| A Study of AL58805 in Patients With Advanced Tumors (NCT07179081) | Advenchen Laboratories Nanjing Ltd. | 2020-12-20 |
| A Phase Ib / IIA Study of AL8326 in Small Cell Lung Cancer (NCT04890795) | Advenchen Laboratories Nanjing Ltd. | 2020-10-19 |
Track Advenchen Laboratories Nanjing Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.